A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)

NCT03274206 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia Grade 2/3

Interventions

BIOLOGICAL: BLS-ILB-E710c
DRUG: Placebo

Sponsor

BioLeaders Corporation